MedTrace Logo

Evaluation of Intestinal Microbiome in Obese Kids

NCT00816296 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-08-24

No results posted yet for this study

Summary

The goal of this study is to investigate comparisons between the intestinal microbiome in patients with obesity and in patients with obesity and Non-Alcoholic Fatty Liver Disease (NAFLD). With this protocol we hope to better understand how the microbiome of each individual works with disease progression.

Conditions

  • Obesity
  • Non-Alcoholic Fatty Liver Disease

Interventions

OTHER

Blood Draw

2 tablespoons of blood will be drawn from participants at study entry, 3 months after study entry, and 6 months after study entry.

OTHER

Stool collection

Stool will be collected from participants 3 times during the study -- at study entry, 3 months from study entry, and 6 months after study entry.

OTHER

BodPod Measurement

Body composition will be measured using a BodPod at study entry, 3 months after study entry, and 6 months after study entry.

OTHER

Liver Ultrasound

A liver ultrasound will be performed at study entry and 6 months after study entry.

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Vincent Biank, MD · Children's Hospital and Health System Foundation, Wisconsin

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00816296 on ClinicalTrials.gov